Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients

Trial Profile

Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Jul 2017

At a glance

  • Drugs Dalbavancin (Primary) ; Dalbavancin (Primary)
  • Indications Bacterial peritonitis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 17 Jul 2017 Planned initiation date changed from 1 Jun 2017 to 1 Aug 2017.
    • 04 May 2017 Planned initiation date changed from 1 Apr 2017 to 1 Jun 2017.
    • 02 Mar 2017 Planned initiation date changed from 1 Feb 2017 to 1 Apr 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top